Intake consultation (video/telephone)
This video/telephone intake interview takes about an hour. Sometimes longer it depends from patient to patient.
Screening and creating the Advisory Report
Support during treatment
For patients who use medicinal cannabis is it important that they receive support and be followed up! Sometimes the patient has problems with the dose titration or there is still no symptom relief after 2 weeks of treatment. That is why it is important that the patient or the attending physician can always contact us. This can be done via email or telephone and even if necessary via a video call. Everyone benefits from a successful treatment and that the best solution is sought in case of questions or difficulties.
After two months of treatment, the patient is asked to participate in an evaluation survey. This is completely free and without obligation for the patient. The questionnaire is replied via an app that is currently being developed. The questionnaire includes questions about the patient’s experience with his treatment of medicinal cannabis. These data serve to constantly improve our services, to refine the treatments and possibly build further knowledge and data for use in the medical corps. This survey is non-committal and completely anonymous (the information obtained is not linked to a name) !!!
The price of 60 euros includes:
a) The preparation of the advisory report*
b) Possibly contact (after written permission from the patient) with the attending physician for questions and information via email and/or telephone
c) Additional assistance (via email and/or telephone) during the treatment if the patient or the attending physician have questions or need assistance.
d) Evaluation survey (if patient agrees) after 2 months of treatment
*An intake interview does not automatically entitle you to an advisory report. This will only be made after payment of its cost price (60 euros). We make an objective analysis in good conscience and an advisory report can also (in some cases) give a negative advice if, for example, the patient could not benefit, or that there would be too many contraindications.
Note: We take your data and privacy very seriously! Therefore, no data is exchanged outside of our own team. Only the nurse Emelie Vanhoenacker and the pharmacist Igna Huyghe are in possession of the data of the patient. Both are also bound by their medical professional secrecy. Patient information is only exchanged with the attending physician if the patient has given his/her written consent.
Copyright Cannabis Patient Care © All Rights Reserved 2018